Adalimumab, sold under the brand name?Humira, among others, is a?monoclonal antibody?used to treat?rheumatoid arthritis,?psoriatic arthritis,?ankylosing spondylitis,?Crohn's disease,?ulcerative colitis,?plaque psoriasis,?hidradenitis suppurativa,?uveitis, and?juvenile idiopathic arthritis.[23][24][25]?It is administered by?injection under the skin.
This report contains market size and forecasts of Adalimumab Drug in Global, including the following market information:
Global Adalimumab Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Adalimumab Drug market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Adalimumab Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Adalimumab Drug include Cambridge Antibody Technology, BASF, AbbVie, MABURA, Exemptia, Amgen, Sandoz, Boehringer Ingelheim and Mylan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Adalimumab Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adalimumab Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Adalimumab Drug Market Segment Percentages, by Type, 2021 (%)
Adalimumab
Adalimumab Biosimilar
Global Adalimumab Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Adalimumab Drug Market Segment Percentages, by Application, 2021 (%)
Adult
Children
Global Adalimumab Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Adalimumab Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adalimumab Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Adalimumab Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cambridge Antibody Technology
BASF
AbbVie
MABURA
Exemptia
Amgen
Sandoz
Boehringer Ingelheim
Mylan
Biogen
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Adalimumab Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adalimumab Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adalimumab Drug Overall Market Size
2.1 Global Adalimumab Drug Market Size: 2021 VS 2028
2.2 Global Adalimumab Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adalimumab Drug Players in Global Market
3.2 Top Global Adalimumab Drug Companies Ranked by Revenue
3.3 Global Adalimumab Drug Revenue by Companies
3.4 Top 3 and Top 5 Adalimumab Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Adalimumab Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adalimumab Drug Players in Global Market
3.6.1 List of Global Tier 1 Adalimumab Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Adalimumab Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Adalimumab Drug Market Size Markets, 2021 & 2028
4.1.2 Adalimumab
4.1.3 Adalimumab Biosimilar
4.2 By Type - Global Adalimumab Drug Revenue & Forecasts
4.2.1 By Type - Global Adalimumab Drug Revenue, 2017-2022
4.2.2 By Type - Global Adalimumab Drug Revenue, 2023-2028
4.2.3 By Type - Global Adalimumab Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adalimumab Drug Market Size, 2021 & 2028
5.1.2 Adult
5.1.3 Children
5.2 By Application - Global Adalimumab Drug Revenue & Forecasts
5.2.1 By Application - Global Adalimumab Drug Revenue, 2017-2022
5.2.2 By Application - Global Adalimumab Drug Revenue, 2023-2028
5.2.3 By Application - Global Adalimumab Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Adalimumab Drug Market Size, 2021 & 2028
6.2 By Region - Global Adalimumab Drug Revenue & Forecasts
6.2.1 By Region - Global Adalimumab Drug Revenue, 2017-2022
6.2.2 By Region - Global Adalimumab Drug Revenue, 2023-2028
6.2.3 By Region - Global Adalimumab Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Adalimumab Drug Revenue, 2017-2028
6.3.2 US Adalimumab Drug Market Size, 2017-2028
6.3.3 Canada Adalimumab Drug Market Size, 2017-2028
6.3.4 Mexico Adalimumab Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Adalimumab Drug Revenue, 2017-2028
6.4.2 Germany Adalimumab Drug Market Size, 2017-2028
6.4.3 France Adalimumab Drug Market Size, 2017-2028
6.4.4 U.K. Adalimumab Drug Market Size, 2017-2028
6.4.5 Italy Adalimumab Drug Market Size, 2017-2028
6.4.6 Russia Adalimumab Drug Market Size, 2017-2028
6.4.7 Nordic Countries Adalimumab Drug Market Size, 2017-2028
6.4.8 Benelux Adalimumab Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Adalimumab Drug Revenue, 2017-2028
6.5.2 China Adalimumab Drug Market Size, 2017-2028
6.5.3 Japan Adalimumab Drug Market Size, 2017-2028
6.5.4 South Korea Adalimumab Drug Market Size, 2017-2028
6.5.5 Southeast Asia Adalimumab Drug Market Size, 2017-2028
6.5.6 India Adalimumab Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Adalimumab Drug Revenue, 2017-2028
6.6.2 Brazil Adalimumab Drug Market Size, 2017-2028
6.6.3 Argentina Adalimumab Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Adalimumab Drug Revenue, 2017-2028
6.7.2 Turkey Adalimumab Drug Market Size, 2017-2028
6.7.3 Israel Adalimumab Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Adalimumab Drug Market Size, 2017-2028
6.7.5 UAE Adalimumab Drug Market Size, 2017-2028
7 Players Profiles
7.1 Cambridge Antibody Technology
7.1.1 Cambridge Antibody Technology Corporate Summary
7.1.2 Cambridge Antibody Technology Business Overview
7.1.3 Cambridge Antibody Technology Adalimumab Drug Major Product Offerings
7.1.4 Cambridge Antibody Technology Adalimumab Drug Revenue in Global Market (2017-2022)
7.1.5 Cambridge Antibody Technology Key News
7.2 BASF
7.2.1 BASF Corporate Summary
7.2.2 BASF Business Overview
7.2.3 BASF Adalimumab Drug Major Product Offerings
7.2.4 BASF Adalimumab Drug Revenue in Global Market (2017-2022)
7.2.5 BASF Key News
7.3 AbbVie
7.3.1 AbbVie Corporate Summary
7.3.2 AbbVie Business Overview
7.3.3 AbbVie Adalimumab Drug Major Product Offerings
7.3.4 AbbVie Adalimumab Drug Revenue in Global Market (2017-2022)
7.3.5 AbbVie Key News
7.4 MABURA
7.4.1 MABURA Corporate Summary
7.4.2 MABURA Business Overview
7.4.3 MABURA Adalimumab Drug Major Product Offerings
7.4.4 MABURA Adalimumab Drug Revenue in Global Market (2017-2022)
7.4.5 MABURA Key News
7.5 Exemptia
7.5.1 Exemptia Corporate Summary
7.5.2 Exemptia Business Overview
7.5.3 Exemptia Adalimumab Drug Major Product Offerings
7.5.4 Exemptia Adalimumab Drug Revenue in Global Market (2017-2022)
7.5.5 Exemptia Key News
7.6 Amgen
7.6.1 Amgen Corporate Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Adalimumab Drug Major Product Offerings
7.6.4 Amgen Adalimumab Drug Revenue in Global Market (2017-2022)
7.6.5 Amgen Key News
7.7 Sandoz
7.7.1 Sandoz Corporate Summary
7.7.2 Sandoz Business Overview
7.7.3 Sandoz Adalimumab Drug Major Product Offerings
7.7.4 Sandoz Adalimumab Drug Revenue in Global Market (2017-2022)
7.7.5 Sandoz Key News
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Corporate Summary
7.8.2 Boehringer Ingelheim Business Overview
7.8.3 Boehringer Ingelheim Adalimumab Drug Major Product Offerings
7.8.4 Boehringer Ingelheim Adalimumab Drug Revenue in Global Market (2017-2022)
7.8.5 Boehringer Ingelheim Key News
7.9 Mylan
7.9.1 Mylan Corporate Summary
7.9.2 Mylan Business Overview
7.9.3 Mylan Adalimumab Drug Major Product Offerings
7.9.4 Mylan Adalimumab Drug Revenue in Global Market (2017-2022)
7.9.5 Mylan Key News
7.10 Biogen
7.10.1 Biogen Corporate Summary
7.10.2 Biogen Business Overview
7.10.3 Biogen Adalimumab Drug Major Product Offerings
7.10.4 Biogen Adalimumab Drug Revenue in Global Market (2017-2022)
7.10.5 Biogen Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Adalimumab Drug Market Opportunities & Trends in Global Market
Table 2. Adalimumab Drug Market Drivers in Global Market
Table 3. Adalimumab Drug Market Restraints in Global Market
Table 4. Key Players of Adalimumab Drug in Global Market
Table 5. Top Adalimumab Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Adalimumab Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Adalimumab Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Adalimumab Drug Product Type
Table 9. List of Global Tier 1 Adalimumab Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adalimumab Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Adalimumab Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Adalimumab Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Adalimumab Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Adalimumab Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Adalimumab Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Adalimumab Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Adalimumab Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Adalimumab Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Adalimumab Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Adalimumab Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Adalimumab Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Adalimumab Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Adalimumab Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Adalimumab Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Adalimumab Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Adalimumab Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Adalimumab Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Adalimumab Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Adalimumab Drug Revenue, (US$, Mn), 2023-2028
Table 30. Cambridge Antibody Technology Corporate Summary
Table 31. Cambridge Antibody Technology Adalimumab Drug Product Offerings
Table 32. Cambridge Antibody Technology Adalimumab Drug Revenue (US$, Mn), (2017-2022)
Table 33. BASF Corporate Summary
Table 34. BASF Adalimumab Drug Product Offerings
Table 35. BASF Adalimumab Drug Revenue (US$, Mn), (2017-2022)
Table 36. AbbVie Corporate Summary
Table 37. AbbVie Adalimumab Drug Product Offerings
Table 38. AbbVie Adalimumab Drug Revenue (US$, Mn), (2017-2022)
Table 39. MABURA Corporate Summary
Table 40. MABURA Adalimumab Drug Product Offerings
Table 41. MABURA Adalimumab Drug Revenue (US$, Mn), (2017-2022)
Table 42. Exemptia Corporate Summary
Table 43. Exemptia Adalimumab Drug Product Offerings
Table 44. Exemptia Adalimumab Drug Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen Adalimumab Drug Product Offerings
Table 47. Amgen Adalimumab Drug Revenue (US$, Mn), (2017-2022)
Table 48. Sandoz Corporate Summary
Table 49. Sandoz Adalimumab Drug Product Offerings
Table 50. Sandoz Adalimumab Drug Revenue (US$, Mn), (2017-2022)
Table 51. Boehringer Ingelheim Corporate Summary
Table 52. Boehringer Ingelheim Adalimumab Drug Product Offerings
Table 53. Boehringer Ingelheim Adalimumab Drug Revenue (US$, Mn), (2017-2022)
Table 54. Mylan Corporate Summary
Table 55. Mylan Adalimumab Drug Product Offerings
Table 56. Mylan Adalimumab Drug Revenue (US$, Mn), (2017-2022)
Table 57. Biogen Corporate Summary
Table 58. Biogen Adalimumab Drug Product Offerings
Table 59. Biogen Adalimumab Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Adalimumab Drug Segment by Type in 2021
Figure 2. Adalimumab Drug Segment by Application in 2021
Figure 3. Global Adalimumab Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Adalimumab Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Adalimumab Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adalimumab Drug Revenue in 2021
Figure 8. By Type - Global Adalimumab Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Adalimumab Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Adalimumab Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Adalimumab Drug Revenue Market Share, 2017-2028
Figure 12. US Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Adalimumab Drug Revenue Market Share, 2017-2028
Figure 16. Germany Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Adalimumab Drug Revenue Market Share, 2017-2028
Figure 24. China Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Adalimumab Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Adalimumab Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Adalimumab Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Cambridge Antibody Technology Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BASF Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. AbbVie Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. MABURA Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Exemptia Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sandoz Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Boehringer Ingelheim Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Mylan Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Biogen Adalimumab Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)